Upper Crossed SyndormeNCT06803459
Effects of Baduanjin and PNF on Upper Crossed Syndrome Among University Students in Henan Province，China
A study testing Baduanjin and PNF in people with Upper Crossed Syndorme, run by Universiti Putra Malaysia at 1 site in China.
Trial summary
Upper crossed syndrome (UCS) is a condition threatening the physical health, anxiety level and quality of life of university students. Despite biomechanical and neurological approaches are available, evidence on their practicality and effectiveness remained scarce among university students. Read more about this study
- Who is it for?
- Ages 18 to 23 yearsHealthy volunteers can take part
- Conditions the study is for
- Upper Crossed Syndorme
- What is being tested?
- Baduanjin and PNF
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 90 participants
- Where
- 1 siteChina
- Study dates
- 9 Oct 2024to 30 Nov 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 23 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- (1) FHA≥42°; (2) FSA≥49°; (3) Recurrent neck pain accompanied by dizziness and headache for ≥2 months; (4) Chest tightness, easy to panic, dyspnea. Severe cases with dizziness and headache; (5) The neck head is too long at the desk or the pain is aggravated after fatigue; (6) Tenderness and/or spasms in the neck and shoulder; (7) Neck and back muscles are tense and stiff, and neck motion is limited.
Who cannot join
- (1) Meet the above diagnostic criteria; (2) University students aged 18-23, male or female; (3) No other treatment and no other physical activities during the treatment; (4) Able to complete the whole rehabilitation program as planned; (5) Sign informed consent.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Baduanjin and Proprioceptive Neuromuscular Facilitation on Upper Crossed Syndrome Among University Students in Henan Province，China
Upper crossed syndrome (UCS) is a condition threatening the physical health, anxiety level and quality of life of university students. Despite biomechanical and neurological approaches are available, evidence on their practicality and effectiveness remained scarce among university students. This randomized controlled trial aimed to determine the effectiveness of Baduanjin and Proprioceptive neuromuscular facilitation (PNF) on symptoms of UCS in university students in Henan Province, China. A total of 90 university students with crossed syndrome will be recruited and randomised into intervention (Baduanjin and PNF) and control groups. The intervention groups will undergo a structured exercise therapy or PNF for 12 weeks. The primary outcomes are improvement on neck range of motion and static posture while secondary outcomes are perceived Quality of Life (QoL) and level of anxiety.
Read the detailed description
In this study, the comparative design is referred to as a descriptive approach because of its appropriateness. This study was conducted primarily through an experimental intervention. It was a randomized controlled trial of 12 weeks duration. In this process, the research instruments and markers were prepared and then during the experiment, the comparative study was a descriptive comparative method, which was mainly described by comparing the changes in data before and after the experiment. This study includes three main aspects of the variable study. The first aspect was the range of motion of the neck joints, which consisted of six main variables: head extension, posterior extension, left extension, right extension, left rotation, and right rotation. The second aspect is the static postural index of patients with upper crossed syndrome. The FHA and FSA variables were selected for assessment in this study. The third aspect is the rating of patients' self-perceptions before and after the experiment, including the degree of cervical pain, the degree of cervical disability and the degree of anxiety. Also, these three aspects were the main measurements of the pre-test and post-test.
The specific process of this study was to first recruit subjects through WeChat and then screen them according to the UCS criteria set in this study. After screening, 90 university students with UCS were selected for random grouping. This experiment by different intervention methods can be divided into two experimental groups, Baduanjin group and PNF group, and a control group, that is, no intervention group. After the grouping, a pretest was administered to evaluate mainly from neck range of motion, static posture and self-perception. After the pre-test, each group received the experimental intervention treatment for 12 weeks. 12 weeks later a post-test was administered, which was consistent with the pre-test. The final data collected.
- Conditions
- Upper Crossed Syndorme
- Being tested
- Baduanjin, PNF
- Keywords
- UCS
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BaduanjinOther
36 times.
PNFOther
36 times.
| Study group | Role | What they receive |
|---|---|---|
| Baduanjin | Experimental | This will be an experiment of about 60 minutes three times a week for 12 weeks. Receives: Other: Baduanjin; Other: PNF |
| PNF | Experimental | This will be an experiment of about 60 minutes three times a week for 12 weeks. Receives: Other: Baduanjin; Other: PNF |
| Control Group | No intervention | The subjects performed daily activities for 12 weeks. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Static posture
Static postures are divided into Forward Head Angle and Forward Shoulder Angle.
Measured: 12 weeks
Cervical range of motion (CROM)
Head forward, head back, head left, head right, head left rotation and head right rotation.
Measured: 12 weeks
Pain
Numeric Pain Rating Scale (NPRS)
Measured: 12 weeks
Neck disorder
Neck Disability Index
Measured: 12 weeks
Anxiety
Self-rating Anxiety Scale
Measured: 12 weeks
Quality of life
SF-12 scale
Measured: 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Jan 2025
- Study start9 Oct 2024
- Primary completion15 Oct 2024
- Study completion30 Nov 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Upper Crossed SyndormeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 90 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universiti Putra Malaysia
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Long Canghao, Universiti Putra Malaysia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06803459
- Sponsor's protocol ID
- 20230067
- Status last verified
- Oct 2024
- First submitted
- 26 Jan 2025
- Last updated
- 31 Jan 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Baduanjin and Proprioceptive Neuromuscular Facilitation on Upper Crossed Syndrome Among University Students in Henan Province，China
- ClinicalTrials.gov ID
- NCT06803459
- Acronym / sponsor ID
- 20230067
- Conditions
- Upper Crossed Syndorme
- Keywords
- UCS
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 90 participants (actual)
- Lead sponsor
- Universiti Putra MalaysiaUniversity, hospital or other
- Study start
- 9 Oct 2024 (actual)
- Primary completion
- 15 Oct 2024 (actual)
- Study completion
- 30 Nov 2024 (actual)
- First posted
- 31 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Upper crossed syndrome (UCS) is a condition threatening the physical health, anxiety level and quality of life of university students. Despite biomechanical and neurological approaches are available, evidence on their practicality and effectiveness remained scarce among university students. This randomized controlled trial aimed to determine the effectiveness of Baduanjin and Proprioceptive neuromuscular facilitation (PNF) on symptoms of UCS in university students in Henan Province, China. A total of 90 university students with crossed syndrome will be recruited and randomised into intervention (Baduanjin and PNF) and control groups. The intervention groups will undergo a structured exercise therapy or PNF for 12 weeks. The primary outcomes are improvement on neck range of motion and static posture while secondary outcomes are perceived Quality of Life (QoL) and level of anxiety.
Detailed description
In this study, the comparative design is referred to as a descriptive approach because of its appropriateness. This study was conducted primarily through an experimental intervention. It was a randomized controlled trial of 12 weeks duration. In this process, the research instruments and markers were prepared and then during the experiment, the comparative study was a descriptive comparative method, which was mainly described by comparing the changes in data before and after the experiment. This study includes three main aspects of the variable study. The first aspect was the range of motion of the neck joints, which consisted of six main variables: head extension, posterior extension, left extension, right extension, left rotation, and right rotation. The second aspect is the static postural index of patients with upper crossed syndrome. The FHA and FSA variables were selected for assessment in this study. The third aspect is the rating of patients' self-perceptions before and after the experiment, including the degree of cervical pain, the degree of cervical disability and the degree of anxiety. Also, these three aspects were the main measurements of the pre-test and post-test.
The specific process of this study was to first recruit subjects through WeChat and then screen them according to the UCS criteria set in this study. After screening, 90 university students with UCS were selected for random grouping. This experiment by different intervention methods can be divided into two experimental groups, Baduanjin group and PNF group, and a control group, that is, no intervention group. After the grouping, a pretest was administered to evaluate mainly from neck range of motion, static posture and self-perception. After the pre-test, each group received the experimental intervention treatment for 12 weeks. 12 weeks later a post-test was administered, which was consistent with the pre-test. The final data collected.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Baduanjin | Experimental | Other: Baduanjin, Other: PNFThis will be an experiment of about 60 minutes three times a week for 12 weeks. |
| PNF | Experimental | Other: Baduanjin, Other: PNFThis will be an experiment of about 60 minutes three times a week for 12 weeks. |
| Control Group | No intervention | –The subjects performed daily activities for 12 weeks. |
Who may qualify
- Ages
- 18 to 23 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- (1) FHA≥42°; (2) FSA≥49°; (3) Recurrent neck pain accompanied by dizziness and headache for ≥2 months; (4) Chest tightness, easy to panic, dyspnea. Severe cases with dizziness and headache; (5) The neck head is too long at the desk or the pain is aggravated after fatigue; (6) Tenderness and/or spasms in the neck and shoulder; (7) Neck and back muscles are tense and stiff, and neck motion is limited.
Key exclusion criteria (1 listed)
- (1) Meet the above diagnostic criteria; (2) University students aged 18-23, male or female; (3) No other treatment and no other physical activities during the treatment; (4) Able to complete the whole rehabilitation program as planned; (5) Sign informed consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Baduanjin36 times. | Other | Baduanjin, PNF |
| PNF36 times. | Other | Baduanjin, PNF |
Primary outcome
Static posture
Time frame: 12 weeks
Static postures are divided into Forward Head Angle and Forward Shoulder Angle.
Cervical range of motion (CROM)
Time frame: 12 weeks
Head forward, head back, head left, head right, head left rotation and head right rotation.
Pain
Time frame: 12 weeks
Numeric Pain Rating Scale (NPRS)
Neck disorder
Time frame: 12 weeks
Neck Disability Index
Anxiety
Time frame: 12 weeks
Self-rating Anxiety Scale
Quality of life
Time frame: 12 weeks
SF-12 scale
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Jan 2025.
Related trials for Upper Crossed Syndorme
Not yet recruiting
Dynamic Neuromuscular Stabilization Versus Corrective Exercises in Upper Cross Syndrome
Upper Crossed Syndrome, Upper Cross Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Baduanjin and PNF in people with Upper Crossed Syndorme, run by Universiti Putra Malaysia at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Static posture (time frame: 12 weeks). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2025.